Beck
Beck received their PhD in Chemistry from MIT in 2020, where they designed and applied peptides to deliver large biomolecular drugs. Prior to that, they received a BS in Chemistry with a Biology minor, summa cum laude, from Baylor University.
Richard P.
Richard studied Chemical Engineering at the University of Auckland, and subsequently received his PhD in Materials Science from MIT. He currently works as a technology investor at a venture capital firm.
Isaac
Isaac earned his BA in Russian and East European Studies and his MPH in Health Policy and Global Health at Yale. He earned his MD at the Icahn School of Medicine at Mount Sinai, and is now a resident in otolaryngology at Harvard.